Author

Anna Cochrane

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alice E. KnaptoniD· 1 shared Alice P. SowtoniD· 1 shared Andrew J. MurrayiD· 1 shared Areesha NazeeriD· 1 shared Benjamin D. Thackray· 1 shared Cecilia CastroiD· 1 shared Dino A. GiussaniiD· 1 shared Julia BabutaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Alice E. KnaptonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hepatic HIF2α modulates extra-hepatic disease-associated phenotypes during metabolic dysfunction-associated steatotic liver disease

Lorenz M.W. Holzner, Rosa M. Korpershoek, Youguo Niu, Anna Cochrane, Paula M. Darwin, Julia Babuta, Areesha Nazeer, Cecilia Castro, Alice P. Sowton, Alice E. Knapton, Benjamin D. Thackray, Julian Leether Griffin, Zoe Hall, Dino A. Giussani, Rob C. I. Wüst, Andrew J. Murray

This study investigates the role of hepatic HIF2α in MASLD, finding that its deletion leads to extra-hepatic complications like cardiac dysfunction and lean mass loss without protecting against liver disease progression.

bioRxiv · May 5, 2026 · PreprintPhysiology